Shuangni Yu

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital · ORCID：0000-0002-3745-1097

发表论文 85 篇 · 总被引 2515 次 · h-index 29

代表论文

• Analysis of a novel immune checkpoint, Siglec‐15, in pancreatic ductal adenocarcinoma (2022 · The Journal of Pathology Clinical Research · 被引 57)
• Targeting N-glycosylation of 4F2hc mediated by glycosyltransferase B3GNT3 sensitizes ferroptosis of pancreatic ductal adenocarcinoma (2023 · Cell Death and Differentiation · 被引 55)
• Solid Pseudopapillary Neoplasms of the Pancreas: Clinicopathologic Analysis and a Predictive Model (2023 · Modern Pathology · 被引 53)
• PD‐L1 and PD‐L2 expression in pancreatic ductal adenocarcinoma and their correlation with immune infiltrates and DNA damage response molecules (2022 · The Journal of Pathology Clinical Research · 被引 40)
• Genomic and TCR profiling data reveal the distinct molecular traits in epithelial ovarian cancer histotypes (2022 · Oncogene · 被引 30)
• Intratumoral neutrophil extracellular traps are associated with unfavorable clinical outcomes and immunogenic context in pancreatic ductal adenocarcinoma (2022 · Frontiers in Immunology · 被引 20)